Hypertonic saline
Trials 60
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 17 trials | ||||||
| Phase 1 | NCT02947126 | Jan 2017 → Feb 2020 | cystic fibrosis | Tim Corcoran | Completed | No outcome recorded |
| Phase 1 | NCT02141191 | Jun 2014 → Oct 2015 | cystic fibrosis | University of Pittsburgh | Completed | No outcome recorded |
| Phase 1 | NCT01713595 | Oct 2013 → May 2015 | pulmonary edema | Mayo Clinic | Withdrawn | No outcome recorded |
| Phase 1 | NCT01667666 | May 2012 → Nov 2018 | acute lung injury, adult acute respiratory distress syndrome | Denver Health and Hospital Authority | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT00753987 | Mar → Jul 2006 | cystic fibrosis | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 1 | NCT00181077 | Jun 2003 → Apr 2006 | preeclampsia | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT00359697 | — | intracranial hypertension | Thomas Jefferson University | Unknown | No outcome recorded |
| Phase 1/26 trials | ||||||
| Phase 1/2 | NCT06370975 | Aug 2024 → Aug 2025 | — | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT02432157 | Jan 2015 → Jan 2017 | intracranial vasospasm, subarachnoid hemorrhage | Thomas Jefferson University | Unknown | No outcome recorded |
| Phase 1/2 | NCT01945944 | Oct 2013 → Apr 2014 | respiratory failure | University Hospitals Cleveland Medical Center | Completed | No outcome recorded |
| Phase 1/2 | NCT01605357 | Jul 2012 → Jul 2013 | brain edema, traumatic brain injury | Massachusetts General Hospital | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT01355796 | May 2011 → Feb 2015 | cystic fibrosis | Joseph Zabner | Completed | No outcome recorded |
| Phase 1/2 | NCT01612494 | Mar 2010 → Apr 2012 | — | University of California, San Diego | Completed | No outcome recorded |
| Phase 24 trials · 1 met primary | ||||||
| Phase 2 | NCT03276494 | Apr 2017 → Apr 2018 | brain edema, intracranial hypotension, stroke disorder | Ohio State University | Completed | No outcome recorded |
| Phase 2 | NCT02871778 | Aug 2016 → Nov 2018 | primary ciliary dyskinesia | Parion Sciences | Completed | Met primary |
| Phase 2 | NCT02805595 | Aug 2016 → Nov 2022 | hidradenitis suppurativa | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT01619657 | Jun 2012 → Nov 2016 | cystic fibrosis | Heidelberg University | Completed | No outcome recorded |
| Phase 2/32 trials · 1 met primary | ||||||
| Phase 2/3 | NCT02950883 | Mar 2015 → Dec 2020 | cystic fibrosis | University of Washington, the Collaborative Health Studies Coordinating Center | Completed | Met primary |
| Phase 2/3 | NCT00151905 | Nov 2003 → Sep 2006 | bronchiolitis | Sheikh Khalifa Medical City | Completed | No outcome recorded |
| Phase 311 trials · 1 met primary · 4 missed | ||||||
| Phase 3 | NCT04140214 | Jun 2018 → Sep 2024 | bronchiectasis | Belfast Health and Social Care Trust | Completed | No outcome recorded |
| Phase 3 | NCT03300648 | Jan 2018 → Dec 2023 | cerebral malaria | Michigan State University | Completed | No outcome recorded |
| Phase 3 | NCT02782520 | Aug 2016 → Oct 2017 | — | University Hospital, Grenoble | Completed | No outcome recorded |
| Phase 3 | NCT04812574 | Jan 2014 → Apr 2018 | female stress incontinence | Turgut Ozal University | Completed | No outcome recorded |
| Phase 3 | NCT01777347 | Oct 2012 → Apr 2014 | acute bronchiolitis | Assistance Publique - Hôpitaux de Paris | Completed | Missed primary |
| Phase 3 | NCT01271114 | Jun 2012 → Dec 2013 | infectious disease with sepsis | Hospital General de Ciudad Real | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT01028339 | Jul 2008 → Jun 2012 | traumatic brain injury | Central Directorate of the Army Health Service | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT00635141 | Mar → Dec 2008 | cystic fibrosis | The Hospital for Sick Children | Completed | Met primary |
| Phase 3 | NCT00316004 | May 2006 → May 2009 | traumatic brain injury | University of Washington | Terminated | Missed primary |
| Phase 3 | NCT00316017 | May 2006 → Aug 2009 | — | University of Washington | Terminated | Missed primary |
| Phase 3 | NCT00271310 | Sep 2000 → Nov 2003 | cystic fibrosis | Royal Prince Alfred Hospital, Sydney, Australia | Completed | Missed primary |
| Phase 412 trials · 1 met primary · 3 missed | ||||||
| Phase 4 | NCT04921943 | May 2021 → Dec 2025 overdue | pulmonary non-tuberculous mycobacterial infection | Oregon Health and Science University | Recruiting | No outcome recorded |
| Phase 4 | NCT03880903 | Jul 2020 → Mar 2021 | acute bronchiolitis | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT03738735 | Jan 2019 → Jan 2020 | rotator cuff syndrome | Rothman Institute Orthopaedics | Unknown | No outcome recorded |
| Phase 4 | NCT03324477 | Nov 2017 → Dec 2023 | urethral syndrome | Nazmy Edward Seif | Completed | No outcome recorded |
| Phase 4 | NCT02266875 | Oct 2014 → Jan 2017 | chronic obstructive pulmonary disease | OhioHealth | Completed | Missed primary |
| Phase 4 | NCT01973140 | Nov 2013 → Dec 2015 | — | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT01834820 | Jan 2013 → Jun 2015 | bronchiolitis | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | Completed | No outcome recorded |
| Phase 4 | NCT01745081 | Sep 2012 → Sep 2014 | intracranial hypertension | University of Sherbrooke | Unknown | No outcome recorded |
| Phase 4 | NCT01871857 | Nov 2010 → Aug 2012 | acute bronchiolitis | Le Bonheur Children's Hospital | Completed | Missed primary |
| Phase 4 | NCT01247064 | Oct 2010 → Dec 2011 | bronchiolitis | Children's Hospital of Philadelphia | Completed | Missed primary |
| Phase 4 | NCT01016249 | Apr 2007 → Apr 2008 | acute bronchiolitis | Hamad Medical Corporation | Completed | Met primary |
| Phase 4 | NCT00469716 | Apr 2007 → May 2008 | respiratory failure | Haukeland University Hospital | Completed | No outcome recorded |
| Phase not applicable18 trials · 1 met primary · 1 missed | ||||||
| — | NCT07647575 | Oct 2025 → Apr 2028 expected | bronchiectasis, pulmonary non-tuberculous mycobacterial infection | Taipei Veterans General Hospital, Taiwan | Recruiting | No outcome recorded |
| — | NCT07605273 | Jun → Dec 2025 | corneal edema | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT06226402 | Sep 2023 → Sep 2024 | acute respiratory distress syndrome | Tanta University | Unknown | No outcome recorded |
| — | NCT04787198 | Oct 2022 → Dec 2024 | — | Aalborg University | Unknown | No outcome recorded |
| — | NCT04341688 | Dec 2021 → Jun 2022 | COVID-19 | Aga Khan University | Unknown | No outcome recorded |
| — | NCT07411950 | Jan 2021 → May 2025 | chronic pain syndrome, radiculopathy | EPC Education s.r.o. | Completed | No outcome recorded |
| — | NCT03750136 | Dec 2018 → Jan 2023 | nephrotic syndrome | Medical University of Bialystok | Unknown | No outcome recorded |
| — | NCT03940118 | Jun 2018 → Apr 2019 | tracheal disorder | Hospital San Carlos, Madrid | Completed | No outcome recorded |
| — | NCT03174483 | Jun 2017 → Jun 2018 | chronic rhinosinusitis | Assiut University | Unknown | No outcome recorded |
| — | NCT04001218 | Apr → Sep 2015 | — | Aalborg University | Completed | No outcome recorded |
| — | NCT02378467 | Mar 2015 → Aug 2018 | cystic fibrosis | University of Washington, the Collaborative Health Studies Coordinating Center | Completed | Met primary |
| — | NCT02834819 | Sep 2013 → Sep 2015 | bronchiolitis | University of Colorado, Denver | Terminated | No outcome recorded Stop: Business |
| — | NCT01238848 | Dec 2010 → Oct 2011 | acute bronchiolitis | Hospital General de Niños Pedro de Elizalde | Completed | No outcome recorded |
| — | NCT01031706 | Sep 2009 → Jul 2012 | cystic fibrosis | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| — | NCT00709280 | Apr 2009 → Oct 2011 | cystic fibrosis | CF Therapeutics Development Network Coordinating Center | Completed | Missed primary |
| — | NCT00546663 | Sep 2007 → May 2008 | cystic fibrosis | CF Therapeutics Development Network Coordinating Center | Completed | No outcome recorded |
| — | NCT00199511 | Jan 2005 → Apr 2007 | primary brain neoplasm | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| — | NCT00142090 | Nov 2004 → Dec 2005 | traumatic brain injury, traumatic encephalopathy | Rady Children's Hospital, San Diego | Completed | No outcome recorded |
| Comparator or background therapy29 trials | ||||||
| Phase 0 | NCT06174584 Comparator | Feb 2021 → Jan 2022 | rectal prolapse | Shaheed Zulfiqar Ali Bhutto Medical University | Completed | No outcome recorded |
| Phase 0 | NCT04686344 Comparator | Dec 2020 → Aug 2021 | optic nerve disorder | Cairo University | Completed | No outcome recorded |
| Phase 1 | NCT01223183 Comparator | Sep 2010 → Dec 2012 | cystic fibrosis | University of Pittsburgh | Completed | No outcome recorded |
| Phase 1/2 | NCT00928135 Comparator | Jan 2013 → Apr 2018 | cystic fibrosis | Joseph Zabner | Completed | No outcome recorded |
| Phase 2 | NCT04671407 Comparator | Jan 2021 → Dec 2022 | — | Kaplan Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT02709109 Background | Feb 2016 → Sep 2017 | cystic fibrosis | Parion Sciences | Completed | Missed primary |
| Phase 2 | NCT02585531 Comparator | Nov 2015 → Feb 2017 | bronchiolitis | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | Unknown | No outcome recorded |
| Phase 2 | NCT01954290 Comparator | Sep 2015 | brain edema, stroke disorder | University of Florida | Withdrawn | No outcome recorded |
| Phase 2 | NCT02343445 Background | Apr 2015 → Feb 2016 | cystic fibrosis | Parion Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00677729 Comparator | Nov 2008 → Apr 2009 | bronchiolitis | Queen's University | Completed | No outcome recorded |
| Phase 2 | NCT00696540 Background | Jun → Sep 2008 | bronchiolitis | University Diego Portales | Unknown | No outcome recorded |
| Phase 3 | NCT06110429 Comparator | Jan 2024 → Jun 2025 | intracranial hypertension | University Hospital, Geneva | Unknown | No outcome recorded |
| Phase 3 | NCT01111682 Comparator | Apr → Nov 2010 | intracranial hypertension, traumatic brain injury | University of Cincinnati | Terminated | No outcome recorded |
| Phase 3 | NCT00484263 Comparator | Dec 2007 → Oct 2009 | bronchiectasis | The Alfred | Completed | No outcome recorded |
| Phase 4 | NCT04765033 Comparator | Feb 2021 → Aug 2023 | bronchiectasis | University of Malaya | Completed | No outcome recorded |
| Phase 4 | NCT03280745 Comparator | Feb 2018 → May 2019 | cardiac valvular defect, cardiovascular disorder | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
| Phase 4 | NCT02538458 Comparator | Nov 2014 → Mar 2016 | acute bronchiolitis | University Hospital, Grenoble | Completed | No outcome recorded |
| Phase 4 | NCT01276821 Comparator | Jan → Apr 2011 | bronchiolitis | Dr. Aayush Khanal, MD | Completed | No outcome recorded |
| Phase 4 | NCT01377792 Comparator | Mar 2009 → May 2011 | cystic fibrosis | Adelaida Lamas Ferreiro | Completed | No outcome recorded |
| — | NCT07286409 Comparator | Jan → Dec 2026 expected | acute respiratory distress syndrome | Tanta University | Not yet recruiting | No outcome recorded |
| — | NCT06069336 Comparator | Nov 2023 → Apr 2025 | acute bronchiolitis | Szpital im. Św. Jadwigi Śląskiej | Completed | No outcome recorded |
| — | NCT04314674 Comparator | Apr 2020 → Apr 2022 | adult glioblastoma, metastatic malignant neoplasm in the brain | Istanbul University | Unknown | No outcome recorded |
| — | NCT04146311 Comparator | Oct 2019 → Nov 2020 | osteoarthritis, knee | Aalborg University | Completed | No outcome recorded |
| — | NCT03741257 Comparator | Nov 2018 → Nov 2019 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT03614273 Comparator | Mar 2015 → Feb 2016 | bronchiolitis | Maulana Azad Medical College | Completed | No outcome recorded |
| — | NCT02460510 Comparator | Jun 2014 → Nov 2015 | acute liver failure | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT01108744 Comparator | Jan 2012 → Jan 2014 | intracranial hypertension | Beth Israel Deaconess Medical Center | Withdrawn | No outcome recorded |
| — | NCT01073527 Comparator | Jan 2009 → Jul 2011 | asthma | Wolfson Medical Center | Completed | No outcome recorded |
| — | NCT00671723 Comparator | Oct 2006 → Jul 2008 | lung disorder | University of Oklahoma | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2017-10-25 | Vertex Pharmaceuticals Incorporated | Results Vertex Reports Third-Quarter 2017 Financial Results vrtx.com ↗
In patients being treated with ORKAMBI, the addition of hypertonic saline resulted in a decrease in ppFEV1 of 0.1 percentage points at Day 28. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2017-10-25 | Vertex Pharmaceuticals Incorporated | Vertex Reports Third-Quarter 2017 Financial Results vrtx.com ↗ |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 90 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hypertonic saline | “Hypertonic saline: Nebulized hypertonic saline has been suggested as a potential therapy for ARDS patients due to its ability to reduce airway inflammation and improve...” NCT07286409 ↗88“Nebulized hypertonic saline (HS) has been shown to increase mucociliary clearance in the airways of individuals with healthy lungs.” NCT01247064 ↗ “After the head fixation 3 mL.kg-1 %3 hypertonic saline will be administered over the 20 min intravenously.” NCT04314674 ↗ “The two hypertonic solutions most commonly used are Mannitol 20% and Hypertonic Saline 7.5%.” NCT00199511 ↗ “Periurethral hypertonic saline (10% NaCl) injection” NCT04812574 ↗ “2% hypertonic saline (Plabottle® by Otsuka Inc.)” PMID 32928313 ↗ Sep 2020 “nebulized hypertonic saline (HS) treatment” PMID 28586918 ↗ Aug 2017 “Hypertonic saline (HTS) is a compound” NCT02432157 ↗ “hypertonic saline (10 mL)” NCT07411950 ↗ “Drug: Hypertonic saline” NCT01355796 ↗ |
| Known as | ClNa 3% (sodium chloride 3%) | “ClNa 3% (sodium chloride 3%)” NCT01238848 ↗ |
| Known as | HTS | “There has been substantial retrospective data and limited prospective data in children which suggests that hypertonic saline (HTS) can improve the control of intracranial...” NCT00142090 ↗2“Inhalation of hypertonic saline (HTS) has short term positive effects on airways clearance in non-cystic fibrosis (CF) bronchiectasis, however its long term effects are unknown.” PMID 22349069 ↗ Feb 2012 “Hypertonic saline (HTS) is a compound” NCT02432157 ↗ |
| Known as | Hyper-Sal, inhaled saline | “Hyper-Sal™, inhaled saline” NCT02378467 ↗ |
| Known as | hyperosmolar saline | “Hyperosmolar saline is an irrigation solution with a higher concentration of solutes that will be used intraoperatively to washout the surgical field.” NCT03738735 ↗ |
| Known as | Hypertonic Saline Solution | “Sodium Lactate Versus Hypertonic Saline Solution in the Treatment of Intracranial Hypertensive Episodes in Severe Brain Injured Patients” NCT06110429 ↗ |
| Known as | Plabottle | “2% hypertonic saline (Plabottle® by Otsuka Inc.)” PMID 32928313 ↗ Sep 2020 |
| Action | Inhibit | “exerts inhibitory effects in several stages of the inflammatory cascade” NCT06226402 ↗ |
| Route | Intravenous | “3% hypertonic saline (salt-water solution) given in a vein” NCT00142090 ↗ |